文献速递冠心病外科瓣膜外科心外重症与机械循环支持

心脏术后低心排综合征的危险因素、资源使用与费用

Risk factors, resource use, and cost of postoperative low cardiac output syndrome.
PubMed 文献 · J Thorac Cardiovasc Surg · 2020-07-16

基于Premier医疗数据库的回顾性观察研究,纳入164家医院59810例心脏手术患者,低心排综合征发生率为10.1%。心源性休克或收缩性(±舒张性)心衰患者风险最高,风险调整后院内死亡风险增加12倍,且住院费用、住院日和ICU时间及30天再入院率均显著增高。

要点

  • 心脏术后低心排综合征发生率为10.1%。
  • 心源性休克或收缩性(±舒张性)心衰患者风险最高。
  • 低心排综合征与风险调整后院内死亡风险增加12倍相关。

核心结论

  • 心脏术后发生低心排综合征的患者死亡率更高、资源使用和医疗费用更多、全因再入院率更高。

研究设计与样本

  • 横断面回顾性观察研究,纳入Premier医疗数据库中2012年7月1日至2014年6月30日期间164家医院59810例心脏手术患者。

主要发现

  • 低心排综合征发生于6067例(10.1%)患者。
  • 心源性休克或收缩性(±舒张性)心衰患者风险最高。
  • 风险调整后院内死亡比值比为12.0(95%CI 10.6-13.5)。
  • 低心排综合征患者风险调整后住院费用中位数(2019美元)为64041(Q1 21439)vs 48086(Q1 16098),P<.001。
  • 低心排综合征患者风险调整后住院日10.1(4.5)vs 8.5(3.8)天、ICU 5.5(2.5)vs 3.3(1.5)天、30天全因再入院率均值16.6%(SD 8.2%)vs 13.9%(SD 7.2%),均P<.001。

临床怎么用

  • 围术期决策应关注心源性休克或收缩性(±舒张性)心衰等高危患者以预防低心排综合征。
  • 低心排综合征增加死亡、费用、住院日和再入院,影响医院绩效指标及联邦降低医疗费用优先事项。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Low cardiac output syndrome complicates recovery after cardiac surgery. We examined the incidence and risk factors for low cardiac output syndrome and its association with postoperative mortality, morbidity, resource use, and cost. METHODS: This cross-sectional retrospective observational study examined patients having cardiac surgery captured in the Premier Healthcare Database. Low cardiac output syndrome was defined as the requirement for postoperative mechanical circulatory support and/or hemodynamic instability requiring prolonged inotropic support. Incidence, risk factors, and association of low cardiac output syndrome with postoperative outcomes, including mortality, hospital and intensive care unit length of stay, hospital readmission, and cost at 30 days, 90 days, and 6 months, were examined. RESULTS: Among 59,810 patients from 164 hospitals having cardiac surgery between July 1, 2012, and June 30, 2014, low cardiac output syndrome developed in 6067 (10.1%) patients. Patients presenting in cardiogenic shock or systolic (± diastolic) heart failure were at greatest risk. Risk-adjusted in-hospital mortality was 12-fold greater with low cardiac output syndrome (odds ratio, 12.0; 95% confidence interval, 10.6-13.5). Risk-adjusted hospital costs (2019$; median [Q1, Q3]) were $64,041 [21,439] in patients who developed low cardiac output syndrome versus $48,086 [16,098] without; P < .001. Increased costs were driven by longer risk-adjusted hospital stay (10.1 [4.5] vs 8.5 [3.8] days); P < .001, intensive care unit (5.5 [2.5] vs 3.3 [1.5] days; P < .001) stay, and all-cause 30-day adjusted hospital readmission rates (mean [SD] 16.6 [8.2]% vs 13.9 [7.2]%; P < .001). CONCLUSIONS: Cardiac surgical patients who develop postoperative low cardiac output syndrome suffer greater mortality and have greater resource use, health care costs, and all-cause readmission, which informs perioperative decision making, and impacts hospital performance metrics and federal priority to reduce health care costs.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Duncan AE, Kartashov A, Robinson SB, et al. Risk factors, resource use, and cost of postoperative low cardiac output syndrome. J Thorac Cardiovasc Surg. 2020. PMID: 32800368. doi:10.1016/j.jtcvs.2020.06.125

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。